PTS Diagnostics Announces New FDA 510(k) Clearance for Extended HDL Range Lipid Panel Test Strips INDIANAPOLIS, April 04, 2017 (GLOBE NEWSWIRE) -- PTS Diagnostics, the US-based manufacturer of point-of-care biometric testing devices, announced today that the US Food and Drug Administration (FDA)...

Life Line Screening Enters Into Multi-Year Contract Extension for CardioChek® Family of Lipid and Glucose Products INDIANAPOLIS, Feb. 15, 2016 (GLOBE NEWSWIRE) -- PTS Diagnostics, the U.S.-based manufacturer of point-of-care biometric testing devices such as the CardioChek® family of analyzers, A1CNow®...